Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440034 · ClinicalTrials.gov registry record · Phase 1
Study of Pioglitazone in Sporadic Inclusion Body Myositis
A Phase 1 study of Nervous System Diseases and Neuromuscular Diseases, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT03440034 is a Phase 1 study of Nervous System Diseases and Neuromuscular Diseases that has completed, run by Johns Hopkins University. The registered enrollment target is 19 participants, below the 323-participant average among 23 other Nervous System Diseases trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03440034, a Phase 1 study of Nervous System Diseases and Neuromuscular Diseases, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
A study looking at the effect of pioglitazone in skeletal muscle of patients with sporadic inclusion body myositis (sIBM).
Conditions Studied
Interventions
- DRUG Pioglitazone
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-05-22 |
| Est. Completion | 2020-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03440034
The ClinicalTrials.gov registry entry for NCT03440034 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 323-participant average among 23 other Nervous System Diseases trials with a reported enrollment target (94% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Nervous System Diseases appearing as the primary indexed condition, and to 1 intervention - of which Pioglitazone is the first listed.
NCT03440034 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03440034 about?
NCT03440034 is a clinical study titled "Study of Pioglitazone in Sporadic Inclusion Body Myositis". A study looking at the effect of pioglitazone in skeletal muscle of patients with sporadic inclusion body myositis (sIBM).
What is the current status of trial NCT03440034?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2018-05-22. Estimated completion is 2020-12-31.
What conditions does trial NCT03440034 study?
This clinical trial studies the following conditions: Nervous System Diseases, Neuromuscular Diseases, Inclusion Body Myositis, Myositis, Muscular Diseases.
What interventions are being tested in trial NCT03440034?
The interventions under investigation include: Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT03440034?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03440034 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nervous System Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Rett Syndrome Registry
RECRUITING
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.